BRUE, or Brief Resolved Unexplained Events, is a medical condition that has been increasingly recognized in the medical community. It is a relatively new diagnosis, and it is still not fully understood. Because of its mysterious nature, it can be difficult for doctors to diagnose and treat. In this article, we will explore the mysterious case of BRUE, what is known about the condition, and how doctors can best diagnose and treat it. BRUE is a relatively new diagnosis, first described in 2016. It is a condition characterized by an event in which an infant stops breathing for at least 20 seconds and then resumes breathing on their own. It is often referred to as an “alarm event” because it is often preceded by an alarm-like sound or sensation. BRUE can occur at any age, but it is most common in infants. It is estimated that BRUE affects up to 1 in 10,000 infants in the United States each year. BRUE is a diagnosis of exclusion, meaning that other possible causes of the event must be ruled out before a diagnosis of BRUE can be made. Common causes of these events include sleep apnea, seizures, gastroesophageal reflux, and airway obstruction. In order for a diagnosis of BRUE to be made, all other possible causes must be ruled out.
The diagnosis of BRUE is based on the history of the event as reported by the parents or caretakers. It is important for doctors to ask questions about the event and to look for any signs or symptoms that may indicate a different cause. Doctors should also perform a physical examination of the infant to look for any signs of underlying illness or injury. In addition to the history and physical examination, doctors may also order tests to help rule out other possible causes. These tests may include an electroencephalogram (EEG) to look for seizure activity, a chest X-ray to look for any abnormalities in the lungs, or a laryngoscopy to look for any blockage in the airway.
Once a diagnosis of BRUE has been made, the goal of treatment is to prevent future events. The most common treatment for BRUE is lifestyle modifications such as avoiding triggers that may cause the events, such as loud noises or sudden movements. Itis also important for parents to ensure that the infant is getting enough rest and is not being over-stimulated. In some cases, medications may also be prescribed to help prevent future events. Commonly used medications include anticonvulsants and sedatives. It is important to note that medications should only be used as a last resort and should be used with caution.
BRUE is a mysterious condition that can be difficult to diagnose and treat. It is important for doctors to take a thorough history and perform a physical examination of the infant in order to rule out other possible causes. Once a diagnosis of BRUE has been made, lifestyle modifications and, in some cases, medications can be used to help prevent future events. With the proper diagnosis and treatment, the prognosis for infants with BRUE is generally good.
1.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
2.
Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.
3.
Understudied mental health challenges among caregivers of cancer patients: A call for targeted support
4.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
5.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
1.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
2.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
3.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
4.
Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy
5.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
5.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation